Forkhead box P3 (FoxP3) 1 regulatory T cells (T regs ) are functionally deficient in systemic lupus erythematosus (SLE), characterized by reduced surface CD25 [the interleukin (IL)-2 receptor alpha chain]. Low-dose IL-2 therapy is a promising current approach to correct this defect. To elucidate the origins of the SLE T reg phenotype, we studied its role through developmentally defined regulatory T cell (T reg ) subsets in 45 SLE patients, 103 SLE-unaffected first-degree relatives and 61 unrelated healthy control subjects, and genetic association with the CD25-encoding IL2RA locus. We identified two separate, uncorrelated effects contributing to T reg CD25.
Summary
Forkhead box P3 (FoxP3)
1 regulatory T cells (T regs ) are functionally deficient in systemic lupus erythematosus (SLE), characterized by reduced surface CD25 [the interleukin (IL)-2 receptor alpha chain]. Low-dose IL-2 therapy is a promising current approach to correct this defect. To elucidate the origins of the SLE T reg phenotype, we studied its role through developmentally defined regulatory T cell (T reg ) subsets in 45 SLE patients, 103 SLE-unaffected first-degree relatives and 61 unrelated healthy control subjects, and genetic association with the CD25-encoding IL2RA locus. We identified two separate, uncorrelated effects contributing to T reg CD25.
(1) SLE patients and unaffected relatives remarkably shared CD25 reduction versus controls, particularly in the developmentally earliest CD4 (2) In contrast, patients and unaffected relatives differed sharply in their activated T reg CD25 state: while relatives as control subjects up-regulated CD25 strongly in these cells during differentiation from naive T regs , SLE patients specifically failed to do so. This CD25 up-regulation depended upon IL2RA genetic variation and was related functionally to the proliferation of activated T regs , but not to their circulating numbers. Both effects were found related to T cell IL-2 production. Our results point to (1) a heritable, intrathymic mechanism responsible for reduced CD25 on early
Introduction
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by combined adaptive and innateimmune aberrations that can affect diverse organs particularly through immune complex-mediated tissue damage. However, the aetiology and pathogenic processes of SLE are not understood fully. Both genetic and environmental factors contribute to immune dysfunction [1] . In the associated breakdown of tolerance, T cells play a key role by amplifying autoimmune responses [2] . Many abnormalities of T lymphocytes have been described in SLE patients, including dysregulated intracellular signal transduction and imbalanced cytokine production [3] , which influence B cell function and autoantibody production. While SLE T cells help B cells to generate the pathogenic autoantibodies, they also fail characteristically to produce sufficient amounts of interleukin (IL)-2 [4] . Limited amounts of IL-2 affect primarily forkhead box P3 (FoxP3)
1 regulatory T cells (T regs ), which depend production and its effects mediated by T regs was supported strongly by the clinical efficacy of low-dose IL-2 therapy in SLE, shown to boost T reg activity and to re-establish tolerance mechanisms that can counter autoimmunity and improve patients' clinical outcome [6, 7] . This is in line with reported T reg aberrations in SLE [8, 9] , despite some discrepancies in previous studies: while some authors had reported decreased circulating T reg proportions in active disease [10] [11] [12] [13] [14] [15] , others had found them normal [16] [17] [18] [19] or even increased [20] [21] [22] [23] [24] . These divergences, however, can be explained largely by a population of aberrant CD4 1 T cells expressing FoxP3 but low or no CD25, which is almost non-existent in healthy individuals but present in significant numbers in SLE [19, [25] [26] [27] where it 'dissociates' FoxP3 from CD25-based T reg quantitation. These CD25-deficient cells have a natural T reg phenotype of deficient functionality [25] , and their frequencies correlate with disease activity and (inversely) with T reg suppressive capacity [28] . The hypothesis that they indicate an SLE-specific T reg dysfunction is consistent with earlier reports of functional T reg defects [15, 16, 29] . [31] , while the FoxP3 low subset can, in part, represent transient FoxP3 expression by non-regulatory T helper (Th) cells [30] . While it was speculated that this could also apply to atypical CD25-deficient T regs in SLE [27] , it is now clear that it is not the case. In fact, no evidence was found for a role of transient FoxP3 expression in SLE, as not only FoxP3 high CD25 high but also CD25 low/negative activated T regs bear strong markers of bona-fide, probably thymus-derived T regs [7, 32] , i.e. high levels of Helios expression [33, 34] , and fully demethylated FoxP3-TSDR [35] . Therefore, T regs in SLE apart from FoxP3 low cells can basically be seen as belonging to a lineage derived from naive T regs .
In complex diseases, the study of unaffected relatives can reveal shared heritable factors that probably contribute to pathogenesis, and separate them from divergent phenotypes which are secondary to disease manifestation. Unaffected relatives of SLE patients frequently present IgG autoantibodies of SLE-associated specificity [36] , although they rarely develop the disease. We have reported previously that these relatives, in contrast to unrelated healthy controls or the patients themselves, showed consistent positive correlations of SLE-associated specific IgG with CD25 1 T regs [37] . This suggested a compensatory role of T regs with the capacity to control autoantibody-related pathogenic effects, eventually allowing the unaffected relatives to avoid manifest disease.
In order to elucidate more clearly the SLE T reg phenotype, which also plays a role in intravenous immunoglobulin (i.v.Ig) therapy [38] , and the T reg -mediated compensation in unaffected relatives, we have now studied the reduced surface CD25 quantitatively in the three classic T reg subsets [30] and tracked it through developmental stages making use of their lineage property. Our results point to two separate contributing effects: (a) a shared, probably intrathymic CD25 reduction that leads to a decreased activation capacity in developmentally early T regs , compensated in unaffected relatives but not patients by (b) a functionally independent CD25 up-regulation that occurs upon peripheral T reg activation.
Materials and methods

Patients and sampling
Peripheral blood samples were collected from 102 SLE patients who fulfilled current American College of Rheumatology (ACR) criteria for SLE, 197 first-degree relatives of the patients from a total of 94 families and 141 unrelated healthy controls upon signed informed consent. Relatives were subjected to a survey questionnaire to rule out clinical SLE, and three who were, in fact, diagnosed with SLE either before or subsequent to our collection were excluded from the study that therefore included 194 unaffected relatives at the end. SLE patients underwent a detailed clinical characterization, the results of which are summarized in Table 1 
Flow cytometry
For flow cytometric analysis, PBMC were washed twice in phosphate-buffered saline (PBS) containing 2% fetal calf serum (FCS) prior to incubation with antibodies and 10 6 cells were incubated for 30 min on ice with anti-CD4-Pacific Orange (Invitrogen, Carlsbad, CA, USA; clone S3.5), anti-CD31-Pacific Blue (exBio, Vestev, Czech Republic; clone MEM-05) anti-CD127-allophycocyanin (APC)/ eFluor780 (eBioscience, San Jose, CA, USA; clone eBioRDR5), anti-CD25-phycoerythrin (PE) (BD; clone 2A3), anti-CD39-PE/cyanin 7 (Cy7) (eBioscience; clone A1) and anti-CD45RO-peridinin chlorophyll (PerCP) 
Cell culture
Isolated 10 6 PBMC were stimulated with phorbol myristate acetate (PMA) (25 ng/ml) and ionomycin (1 lg/ml) for 6 h at 378C in RPMI-1640 medium containing 10% FCS and 10 lg/ml brefeldin A. Immediately after stimulation, the cells were stained with anti-CD3-APC/Cy7 (BioLegend; clone HIT3a), anti-CD4-PerCP (BioLegend; clone RPA-T4), anti-CD8-PE/Cy7 (eBioscience; clone RPA-T8) and anti-CD45RO-Pacific Blue (BioLegend; clone UCHL1). Subsequently, cells were fixed and permeabilized using Cytofix/Cytoperm (BD), washed and stained for intracellular IL-2 in Perm buffer with anti-IL-2-APC [eBioscience; clone MQ1-17H12, in parallel with interferon (IFN)-g and tumour necrosis factor (TNF)-a], assessed cytometrically with a fluorescence activated cell sorter (FACS)Canto II cytometer and analysed using FlowJo software (TreeStar, Inc.).
IL2RA (CD25) genotyping
Genomic DNA was extracted from peripheral blood cells by standard salting-out. Genotyping of 25 locus-spanning single nucleotide polymorphisms (SNPs) ( Table 2 ) was performed on the Sequenom TM platform, as described previously [37] . All 25 typed SNPs passed quality control with call rates above 85% and Hardy-Weinberg equilibrium (P > 0Á01) was fulfilled within the control subjects.
Data analysis
Data were analysed with Igor Pro software (WaveMetrics, Lake Oswego, OR, USA) and a statistical package that we have developed for it (also see [36] [37] [38] ). Pairwise group comparisons of continuous variables were performed by the distribution-independent Mann-Whitney test. Our statistical approach was to compare patients and unaffected relatives separately to a control group, followed by within-group analysis. We did not make all possible groupwise comparisons, and particularly did not directly compare patients and relatives, which were drawn from the same families and cannot be compared irrespective of their familial relations with adequate statistical power. Relations between continuous variables (including genotypes) were characterized by linear correlation coefficients (sometimes partial or semipartial) and tested by linear regression analysis. Multiple linear regression was used to consider covariates. For genetic association, univariate P-values were corrected for multiple comparisons (i.e. the 25 SNPs tested) with the BenjaminiHochberg false discovery rate (FDR) method. P-values below 0Á05 were considered statistically significant.
Results
CD25 reduction on SLE T regs is shared by the patients' first-degree relatives
Comparing quantitative CD25 surface staining intensities in 45 SLE patients, 103 unaffected relatives and 61 unrelated healthy controls, we found CD25 MFI impressively reduced in patients versus controls not only when considering all FoxP3 1 cells (Fig. 2a) , but also within each of their three subsets (depicted in Fig. 1 Fig. S1 ). Subsetwise CD25 levels were particularly interesting. We found that surface CD25 MFIs of the naive and activated T reg subsets were statistically independent from other measures obtained for the respective subset, i.e. CD25 was never significantly correlated with the same subset's circulating numbers, frequencies within total FoxP3 1 or CD4 1 cells, or Ki67 1 proliferating fractions in any of our three study groups (not shown). There were also no significant relations to patients' SLE Disease Activity Index (SLEDAI)-2k disease activity, other clinical characteristics or treatments (Table 1) or to gender or age, except for a marginal R 5 0Á2/P 5 0Á046 age correlation with naive T reg CD25 only within unaffected relatives. Although uncorrelated with surface CD25, circulating T reg numbers were also decreased both in patients and relatives, but less significantly (Supporting information, Fig.  S2 ). In terms of T reg subset numbers per blood volume this was, however, restricted to the activated T regs , which alone accounted for the differences in total Fig. S2 , third column), T reg subset characteristics were no longer shared by patients and relatives -an effect that can, in fact, be explained by a relative over-representation of T regs in SLE patients with lymphopenia and that disappeared when only non-lymphopenic subjects were considered (Supporting information, Fig. S3 ).
Effect 1: characteristic and functionally relevant CD25 reduction already in CD31 1 recent thymic emigrant T regs Like naive Th cells, naive T regs also contain a subpopulation of recent thymic emigrants (RTE), which can be distinguished as the developmentally earliest T regs by their CD31 expression [39] . We studied RTE T regs with specific emphasis and found that their surface CD25 was already reduced strongly, actually showing almost identically low levels in SLE patients and unaffected relatives (1Á5 and 1Á4-fold reduced, respectively) compared to healthy controls (Fig. 3a, mirrored by CD25 -approximations within RTE T regs ; see Supporting information, Fig. S1 ). As human T reg development involves IL-2-driven intrathymic CD25 induction [40] , we asked whether CD25 expression by RTE T regs depended upon the individual capacity to produce IL-2. The CD25 MFI of RTE T regs was indeed found to be correlated positively with the capacity of cultured CD3 1 CD45RO 1 T memory cells to produce IL-2 upon PMA/ionomycin stimulation in SLE patients and also in controls ( Fig. 3b,c ; for IL-2 stainings, for example, see Supporting information, Fig. S4 ). By contrast, RTE T reg CD25 levels were unrelated to patients' SLEDAI-2k disease activity, other clinical characteristics and treatment (Table  1) and to gender and age in all groups, except for a marginal increase with age within unaffected relatives, R 5 0Á25/P 5 0Á02 (not shown). RTE T reg CD25 levels were also completely unrelated to their highly age-dependent and barely group-characteristic circulating numbers and frequencies (Supporting information, Fig. S5 ), as well as to Ki67 1 proliferating fractions (not shown). Instead, we detected a remarkably strong correlation to proportions of activated among total T regs in patients (R 5 0Á53/P 5 3E-4) as well as in unaffected relatives (R 5 0Á42/P 5 2E-5) (Fig. 3d-f) . These activated T reg proportions were found to be correlated far less with CD25 levels when measured on all naive T regs [patients: R 5 0Á29/ not significant (n.s.); relatives: R 5 0Á32/P 5 0Á001], and completely unrelated to CD25 levels of the activated T regs themselves. This suggests that the RTE T reg surface CD25 levels uniquely indicate the conditioning effect that the state of early T regs appears to have on the individual capacity in our SLE risk population to produce high numbers of fully activated peripheral T regs .
Effect 2: CD25 up-regulation in activated versus naive T regs is specifically deficient in manifest SLE
As activated T regs are derived largely from naive T regs [30, 31] but generally show higher surface CD25 levels, we addressed specifically their capacity to up-regulate CD25 when differentiating from naive T regs , measured as the MFI difference between both subsets in the same subject. While there was no significant difference between unaffected relatives and controls, CD25 up-regulation was significantly lower and almost absent in SLE patients (Fig. 4) . Thus, unaffected relatives of SLE patients appeared able to upregulate CD25 in activated T regs to the same extent as healthy controls, while SLE patients had a specific deficiency in this respect. The SLE patients' CD25 up-regulation in activated versus naive T regs was also found to be correlated positively with the individual capacity of their T memory cells to produce IL-2 upon PMA/ionomycin stimulation (Fig. 5a) , as was CD25 in RTE T regs . In contrast, no such correlation was found in unaffected relatives or controls (Fig. 5b) , indicating that the IL-2 dependency of CD25 up-regulation was limited to SLE patients where it was also particularly defective.
CD25 up-regulation in activated T regs was uncorrelated with RTE T reg CD25 levels (effect 1) in relatives and in control subjects, and a positive correlation of both within patients was due entirely to their shared IL-2 dependency (Supporting information, Fig. S6 ). We also detected no significant relations to age, gender, SLEDAI-2k disease activity, clinical characteristics or treatment (not shown). Thus, CD25 up-regulation fulfills all criteria of being an independent second effect contributing to the SLEassociated T reg defect, reflecting peripheral but not thymic influences on T reg CD25 expression.
While CD25 up-regulation in activated T regs was basically uncorrelated with numbers and frequencies of activated T regs , there were negative correlations with naive T regs (Supporting information, Fig. S7 ). Interpreted as precursor consumption accompanying T reg activation, this could particularly explain that among patients, those with virtually absent CD25 up-regulation were paradoxically the ones with most naive T regs also in relation to naive FoxP3 -T helpers (Fig. 5c,d ). Furthermore, in the patients and relatives groups, CD25 up-regulation was correlated positively with Ki67 1 fractions within activated T regs (Fig. 5e,f) suggesting that, apart from recruitment, their proliferation also influences this property.
Effect 1 shows the strongest heritability, and effect 2 is associated to IL2RA (CD25) genetic variants
In order to estimate overall genetic effects on the two described effects contributing to T reg CD25 deficiency in SLE, we addressed their probable heritability within our affected families by assessing familial correlations. Both parental and sibling correlations were indeed found highly significant for effect 1, RTE T reg CD25 (q P 5 0Á73/P 5 2E-12; q S 5 0Á70/P 5 5E-8), indicating a high heritability. For effect 2, CD25 MFI up-regulation, familial correlations were clearly lower but still significant (q P 5 0Á44/P 5 1E-5; q S 5 0Á27/P 5 0Á032). In our control group, where subjects were unrelated, we finally studied whether the two component effects were associated with genetic variation in the IL2RA locus that encodes CD25. For effect 1, RTE T reg CD25, association with two of 25 typed SNPs was univariately significant but did not retain significance upon FDR correction for multiple comparisons ( Table 2 ). In contrast, IL2RA SNP association with effect 2, CD25 MFI up-regulation, was significant also when FDRcorrected. The associated SNPs were located in the IL2RA 5' portion (Table 2) , corresponding to the region where genetic association primarily with type 1 diabetes (T1D) was also reported. In fact, the two SNP alleles that we found associated significantly with reduced CD25 up-regulation were also described as T1D risk alleles [41] .
Discussion
In SLE T regs , a particular surface CD25 reduction 'dissociated' from FoxP3 expression was described previously [25] , while the details and origins of this reduction have not been assessed thoroughly. Studying CD25 in T reg subsets, we could discriminate two independent effects contributing to the reduced surface CD25 in SLE that were both related to individual IL-2 production: effect 1, surface CD25 of the developmentally earliest RTE T regs , was reduced in both SLE patients and unaffected relatives in a largely shared manner; and effect 2, the degree to which T regs up-regulated CD25 upon activation, was only deficient in manifest SLE but not in unaffected relatives. This CD25 upregulation was associated (in controls) with IL2RA genetic variants.
Effect 1 -RTE T reg surface CD25 -likely reflects intrathymic T reg development [40] . It neither depended upon disease manifestation nor did it correlate with disease activity. It was also unrelated to the age-dependent RTE T reg numbers and frequencies, but highly heritable, as suggested by familial correlations. Thus, RTE T reg CD25 clearly does not represent an effect secondary to clinical disease, treatment or age, but rather a primary, largely genetically determined and individually variable 'baseline' CD25 that seems to be set intrathymically, as it is best visible in the developmentally earliest T regs . Most interestingly, RTE T reg CD25 (unlike surface CD25 of activated or overall naive T regs ) was correlated uniquely positively, thus predictive for peripheral proportions of fully differentiated activated T regs in the individual patients and relatives. This suggests that the RTE T reg functional state reflected by their surface CD25 level is crucial for the capacity of subjects at risk for SLE to produce high proportions of activated peripheral T regs .
Effect 2 -CD25 up-regulation in activated versus na€ ıve T regs -demonstrates a specific failure of SLE T regs to increase CD25 expression when differentiating into activated CD45RO
1 T regs in the periphery. This failure was not seen in first-degree unaffected relatives and therefore appears secondary to SLE manifestation (although we observed no relation to clinical features or treatment). Coincident with our earlier report pointing to a compensatory T cell regulation [37] , it can be said that unaffected relatives 'compensate' their shared baseline CD25 reduction in early non-activated T regs (effect 1) by activationdependent up-regulation -a mechanism that could be important for subjects at risk to avoid clinical disease. Unlike effect 1, effect 2 was not associated with increased activated T reg quantities in circulation, while it was related to naive T reg consumption and to activated T reg proliferation. This can be explained by the short-lived nature of activated T regs [30] .
Technically, our quantitation of CD25 up-regulation (effect 2) is based upon the assumption of a common T reg lineage, i.e. that transient FoxP3 expression and peripherally induced T regs do not need to be considered. This seems reasonable to us in this context, as SLE Foxp3 1 T regs , including CD25 low and CD25 -cells, have shown extraordinarily high levels of Helios expression and FoxP3-TSDR demethylation [7, 32] . While Helios expression indicates a thymic origin [33, 34] , cytosine-phosphate-guanine (CpG) demethylation of the FoxP3-TSDR region [35] confirms sustained bona-fide FoxP3 expression. Both markers do not occur in transiently FoxP3-expressing T helpers or induced T regs . Moreover, FoxP3 low cells where transient expression may occur were excluded thoroughly from our cytometric definition of activated T regs .
Our findings add to a series of papers which showed neatly that surface CD25 (but not FoxP3) is the only marker that can reflect the SLE-associated phenotypical [21, 28] and functional [25, 28] T reg impairment appropriately. The two effects acting on reduced T reg CD25 expression described by us here were both related to the capacity of effector cells to produce its ligand, IL-2, which is recognized widely as the most important factor for T reg homeostasis, since the time when it was first demonstrated that IL-2-deficient mice harbour very few T regs with low surface CD25 [42] . The crucial role of IL-2, particularly for peripheral T reg maintenance and expansion, is also generally accepted for the human system [43], and we have recently described its effects particularly in respect to SLEassociated autoantibody profiles [37] . More recently, IL-2 was shown to be similarly important (besides IL-15) for the thymic generation of human T regs [40] . Particularly in SLE, T cells obviously produce insufficient amounts of IL-2 due to altered transcriptional regulation [4] . Accordingly, a recent report demonstrates that the CD25 deficiency of SLE T regs could be reversed efficiently by IL-2 in cell cultures, as well as in patients undergoing low-dose IL-2 therapy [7] . This corresponds with findings that restoring IL-2 production in lupus-prone mice enhanced the generation of CD25
1 FoxP3 1 T regs [44, 45] . Our results suggest that deficient IL-2 in SLE affects surface CD25 in two separate ways in early and in late T regs . Both effects appear genetically influenced. While the early effect 1 showed indirect evidence of (unspecified) genetic factors, the patient-characteristic late effect 2 was found associated with genetic variants in the region of the CD25-encoding locus IL2RA that also conferred T1D risk [41] . Located 5' upstream of the IL2RA locus, the effect linked to these variants is unlikely to alter CD25 molecular properties, but rather transcriptional control by (not well known) transcription factors [46] . Among the different haplotypes that have meanwhile been identified in this region [41, 47] , our findings point mainly to a functionally unexplored rs11594656 haplotype where, conversely, T1D risk variants protected from multiple sclerosis (MS) [48] . For the betterstudied rs2104286 haplotype in the same region, healthy individuals bearing the risk variant for both diseases with low IL-2 receptor signalling [49] also had fewer T regs with reduced suppressive function and less stable FoxP3 expression under limiting IL-2 concentrations [50] . Loss of FoxP3 expression by T regs in IL-2 insufficient conditions is also well documented from mouse experiments [51, 52] and explained by IL-2 mediated transcriptional stabilization [53] . Ex-T regs convert typically into Th17 cells, can easily become pathogenic and cause lung and liver inflammation [51] , arthritis [54] and autoantigen-driven encephalitis [55] . Also in human MS, IL-2-IL2R pathway alterations were linked to decreased FoxP3 expression [56] , and T regs converting to Th17 cells probably contribute to human inflammatory bowel diseases [57] , rheumatoid arthritis [58] and psoriasis [59] by shifting the paradigmatic balance between these two developmentally related cell types [60] . As the relevance of this for SLE remains somewhat unclear, our discrimination of two separate component effects may help to characterize further how the probably multiple associated mechanisms affect each type of autoimmunity.
In SLE patients, defective CD25 expression by T regs was found completely reversible under low-dose IL-2 therapy [7] . In our context, this corresponds most probably to a boost of effect 2, most affected in SLE patients and in fact showing less overall genetic determination (i.e. heritability), thus a more 'acquired' character, than effect 1. However, low-dose IL-2 therapy increased not only CD25 expression but even more impressively the numbers of circulating FoxP3 1 T regs . Interpreted in the context of our results, this also points to the involvement of IL-2 effects on non-activated T regs , possibly even inside the thymus analogously to our effect 1, in addition to peripheral stimulation (effect 2). It will be extremely interesting to determine this in future clinical studies, as well as how the clinical outcome relates to the two effect types, in order to identify optimal therapy schemes for IL-2 and possibly other therapies seeking to improve T reg function.
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Additional Supporting information may be found in the online version of this article at the publisher's web-site: showing their overrepresentation particularly in lymphopenic SLE patients. This over-representation also caused a distribution bias of T reg subset measures within CD4 1 cells: when only non-lymphopenic subjects were considered, the previously detected increase in patients' naive T regs /CD4 1 was abrogated (c), and activated T reg differences corresponded to those found for absolute cell numbers (d). Linear correlation coefficients (R) and significant P-values are shown; n.s. 5 non-significant.
Two effects contribute to SLE T reg defect All measures showed a significant decrease with age in all three groups. Accordingly, group comparisons were calculated with age as a covariate. None of the four measures showed a significant difference between relatives and controls. Patients had significant reductions in absolute numbers (a) and frequencies within naive T regs (d) but not when measured within total forkhead box P3 (FoxP3) As both CD25 component effects depended upon IL-2 producers in patients, we further calculated their partial correlation (i.e. of both regressed against our measures of IL-2 producer proportions). The absence of significance demonstrates that the previously detected correlation was due to an IL-2 effect. Linear correlation coefficients (R) and significant P-values are shown; n.s. 5 non-significant. Fig. S7 . Relations of CD25 up-regulation in activated regulatory T cells (T regs ) (effect 2) to T reg subset measures. We studied the possible relation of CD25 up-regulation in activated T regs (effect 2) to three common measures of naive and activated T reg numbers and frequencies, respectively (analogously to Fig. S2). (a-c) None of the activated T reg measures showed a significant relation when assessed by multiple regression, differentiating the three subject groups by two contrast covariates. Univariately, only activated T regs /CD4
1 measured within patients showed a significant correlation (c) which was, however, ascribable to lymphopenia bias as abrogated when considering only non-lymphopenic subjects analogously to Fig.  S3 . (d-f) In contrast, all three measures of naive recent thymic emigrants (RTE) regulatory T cell (T reg ) numbers or frequencies were found related significantly to decreasing CD25 up-regulation in activated T regs (effect 2) using the same multiple regression approach. Univariate groupwise correlation (although not significant throughout) also remained significant with naive T regs /CD4 1 in patients when considering only non-lymphopenic patients (f). Linear correlation coefficients (R) and significant Pvalues are shown; n.s. 5 non-significant.
